Abstract 4514: Discovery of potent and orally bioavailable degraders of HPK1 based on a novel HPK1 binder

生物利用度 医学 药理学
作者
Zhimin Zhang,Mengqiang Wu,Ling Wang,Xi Yang,Zhiping Zhang,Liubin Guo,Hao Pan,Mengting Zhao,Linli Wang,Sirui Liu,Zhao Dong,Chunhua Jiang,Haowen Zheng,Dongzhou Jeffrey Liu
出处
期刊:Cancer Research [American Association for Cancer Research]
卷期号:84 (6_Supplement): 4514-4514
标识
DOI:10.1158/1538-7445.am2024-4514
摘要

Abstract Background: Proteolysis targeting chimeras (PROTACs) are novel structures designed to target a protein of interest (POI) for ubiquitination and degradation, leading to the selective reduction in the expression levels of the POI. Hematopoietic progenitor kinase 1 (HPK1) is considered a promising target for tumor immunotherapy. PROTAC-involved disruption of HPK1 protein activity enhanced the treatment efficacy of CAR-T-cell-based immunotherapies in different solid tumors and mouse models. Thus, targeting HPK1 by PROTAC to restore T-cell activity is an attractive approach to induce a greater immune responses in cancer. Results: We designed and synthesized a series of HPK1 degraders by tethering our previously discovered novel HPK1 inhibitor with CRBN binder through various linkage. The most potent PROTAC effectively degrades HPK1 proteins in the Ramous cell in a dose-dependent manner and achieves DC50 value <50 nM. The maximum degradation (D max ) values achieved are >90%. Our PROTAC showed EC50 value <100 nM for IL-2 and IFNγ production. PK studies revealed a low clearance, high plasma exposure and oral bioavailability in mice and rats. Furthermore, our PROTAC is shown to induce robust and statistically significant tumor growth inhibition in the MC38 and CT26 syngeneic model with increased T cell signatures observed within the tumor. The PROTAC in combination with anti-PD1 also resulted in robust anti-tumor activity with TGI > 90%. The 14 days DRF experiment shows that the compound has a great safety window(>200 folds). Conclusion: We show here that a potent oral HPK1 degrader demonstrates strong immune cell activation and robust anti-tumor activity in mouse syngeneic tumor models, as a single agent and in combination with anti-PD1. Further evaluation of these potent degraders in additional in vivo studies will continue to build upon our mechanistic understanding of HPK1 degradation as a novel immunomodulatory approach for anti-tumor immunity. Citation Format: Zhimin Zhang, Mengqiang Wu, Ling Wang, Xi Yang, Zhiping Zhang, Liubin Guo, Hao Pan, Mengting Zhao, Linli Wang, Sirui Liu, Zhao Dong, Chunhua Jiang, Haowen Zheng, Dongzhou Liu. Discovery of potent and orally bioavailable degraders of HPK1 based on a novel HPK1 binder [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2024; Part 1 (Regular Abstracts); 2024 Apr 5-10; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2024;84(6_Suppl):Abstract nr 4514.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
英俊的铭的应助被以七采纳,获得10
刚刚
毕长富完成签到,获得积分10
1秒前
分化发布了新的文献求助10
1秒前
QIU完成签到,获得积分10
1秒前
xl的应助被chiwuuuuuu采纳,获得10
1秒前
2秒前
纯情的阁发布了新的文献求助10
2秒前
3秒前
中和皇极的应助被wg采纳,获得10
4秒前
夏汐完成签到,获得积分10
4秒前
871004188完成签到,获得积分10
4秒前
4秒前
苗条乞完成签到,获得积分10
4秒前
风吹麦浪的应助被科研通管家采纳,获得10
5秒前
田様的应助被木鱼风絮采纳,获得10
5秒前
阔达雁的应助被科研通管家采纳,获得30
5秒前
kevin231的应助被科研通管家采纳,获得10
5秒前
英姑的应助被科研通管家采纳,获得10
5秒前
Maestro_S的应助被科研通管家采纳,获得10
6秒前
6秒前
6秒前
核桃的应助被科研通管家采纳,获得30
6秒前
受伤老太发布了新的文献求助10
6秒前
纯情的阁发布了新的文献求助10
6秒前
wanci的应助被科研通管家采纳,获得10
6秒前
阔达雁的应助被科研通管家采纳,获得30
6秒前
6秒前
阔达雁的应助被科研通管家采纳,获得30
6秒前
kevin231的应助被科研通管家采纳,获得10
6秒前
molihuakai的应助被科研通管家采纳,获得10
6秒前
田様的应助被科研通管家采纳,获得10
7秒前
科研通AI2S的应助被科研通管家采纳,获得10
7秒前
JamesPei的应助被科研通管家采纳,获得10
7秒前
7秒前
搜集达人的应助被小陈采纳,获得10
9秒前
十一一完成签到 ,获得积分10
10秒前
纯情的阁发布了新的文献求助10
10秒前
氨基酸发布了新的文献求助10
10秒前
10秒前
斯文败类的应助被HFBB采纳,获得10
10秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
What Else Can I Tell You?: A Pragmatic Study of English Rhetorical Questions as Discursive and Argumentative Acts 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8165225
求助须知:如何正确求助?哪些是违规求助? 9558933
关于积分的说明 21747810
捐赠科研通 7755799
什么是DOI,文献DOI怎么找? 3428894
关于科研通互助平台的介绍 2553184
邀请新用户注册赠送积分活动 2473404